SEC Tracker
Get the app

Bambusa Therapeutics BBTX

Bambusa Therapeutics reports ownership

Shanshan Xu, new insider at Bambusa Therapeutics, Inc.

Form
3
Filed
Importance
Routine
  1. Xu Shanshan owns 823,919 common shares
  2. MiNeng, Inc. Owns 7,415,280 common shares
  3. Xu Shanshan holds 245,181 stock options
  4. Preferred shares convert to common shares before IPO

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bambusa Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX